HC Wainwright reiterated their buy rating on shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $30.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for BioCryst Pharmaceuticals’ FY2026 earnings at $0.63 EPS and FY2027 earnings at $1.08 EPS. […]
Needham & Company LLC reissued their buy rating on shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) in a research report released on Thursday morning, Benzinga reports. They currently have a $12.00 price target on the biotechnology company’s stock, down from their prior price target of $14.00. BCRX has been the topic of several other […]
HC Wainwright reissued their buy rating on shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) in a research note issued to investors on Friday, Benzinga reports. HC Wainwright currently has a $30.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for BioCryst Pharmaceuticals’ FY2026 earnings at $0.63 EPS and FY2027 earnings […]
BioCryst Pharmaceuticals (NASDAQ:BCRX) Given Buy Rating at HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report)’s share price traded down 3.5% on Monday . The stock traded as low as $7.40 and last traded at $7.41. 446,417 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 2,802,669 shares. The stock had previously closed at $7.68. Analysts […]